{{Rsnum
|rsid=4765623
|Gene=SCARB1
|Chromosome=12
|position=124836304
|Orientation=plus
|GMAF=0.3907
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SCARB1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 42.5 | 44.2 | 13.3
| HCB | 34.6 | 52.2 | 13.2
| JPT | 26.5 | 51.3 | 22.1
| YRI | 34.9 | 46.6 | 18.5
| ASW | 29.8 | 57.9 | 12.3
| CHB | 34.6 | 52.2 | 13.2
| CHD | 31.2 | 51.4 | 17.4
| GIH | 46.5 | 41.6 | 11.9
| LWK | 40.9 | 49.1 | 10.0
| MEX | 19.0 | 53.4 | 27.6
| MKK | 30.1 | 53.2 | 16.7
| TSI | 46.1 | 43.1 | 10.8
| HapMapRevision=28
}}
[[rs4765623]] is a SNP in the scavenger receptor class B, member 1 [[SCARB1]] gene.

In a study of 67 mostly Caucasian patients prescribed the atypical antipsychotic [[olanzapine]], carriers of a [[rs4765623]](C) allele were more likely to gain significant weight compared to [[rs4765623]](T;T) carriers, as assessed by physiogenomic analysis of corresponding weight profiles. Two other SNPs, [[rs5092]] and [[rs7412]], were also significantly associated with weight profiles in these patients.{{PMID|17199131}}

{{PMID Auto GWAS
|PMID=21131975
|Trait=None
|Title=Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
|RiskAllele=
|Pval=3E-8
|OR=1.1500
|ORtxt=[1.09-1.20]
|OA=1
}}

{{PMID Auto
|PMID=22131124
|Title=Chromosome 11q13.3 variant modifies renal cell cancer risk in a Chinese population
}}

{{PMID|18072279|OA=1
}} Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}